Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study
<p><strong>Background:</strong> In the UK, 10% of admissions to intensive care units receive continuous renal replacement therapy with regional citrate anticoagulation replacing systemic heparin anticoagulation over the last decade. Regional citrate anticoagulation is now...
Main Authors: | Gould, DW, Doidge, J, Sadique, MZ, Borthwick, M, Hatch, R, MacEwen, C, Young, JD, Watkinson, P |
---|---|
Format: | Report |
Language: | English |
Published: |
NIHR
2022
|
Similar Items
-
Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study
by: Gould, DW, et al.
Published: (2022) -
Regional citrate anticoagulation versus systemic heparin anticoagulation for continuous kidney replacement therapy in intensive care
by: Doidge, JC, et al.
Published: (2022) -
Regional Citrate Anticoagulation or Heparin Anticoagulation for Renal Replacement Therapy in Patients With Liver Failure: A Systematic Review and Meta-Analysis
by: Wenqian Qi PhD, et al.
Published: (2023-05-01) -
Regional citrate anticoagulation for continuous renal replacement therapy in newborns
by: Haixia Huang, et al.
Published: (2023-03-01) -
Adverse events with regional citrate anticoagulation versus heparin anticoagulation during continuous renal replacement therapy: a systematic review and trial sequential analysis
by: Min-min Wang, et al.
Published: (2023-10-01)